A team of scientists from Japan and the University of California, San Diego School of Medicine have created a new mouse model that confirms that mutations of a protein called beta-synuclein promote neurodegeneration.

The discovery creates a potential new target for developing treatments of diseases like Parkinson’s and Alzheimer’s. The work is published in the latest issue of Nature Communications… (Source: Health News from Medical News Today)